Adaptive Biotechnologies Corporation
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $29.9M | $332.7M | $55.0M |
| FY2019 | $341.3M | $912.3M | $96.6M |
| FY2020 | $373.1M | $1.12B | $123.4M |
| FY2021 | $319.2M | $923.3M | $139.1M |
| FY2022 | $392.5M | $856.6M | $90.0M |
| FY2023 | $352.9M | $661.1M | $65.1M |
| FY2024 | $336.9M | $539.4M | $47.9M |
| FY2025 | $287.7M | $512.7M | $70.5M |